vs

Side-by-side financial comparison of Precipio, Inc. (PRPO) and RAPID MICRO BIOSYSTEMS, INC. (RPID). Click either name above to swap in a different company.

RAPID MICRO BIOSYSTEMS, INC. is the larger business by last-quarter revenue ($11.3M vs $6.8M, roughly 1.7× Precipio, Inc.). Precipio, Inc. runs the higher net margin — 7.7% vs -110.8%, a 118.5% gap on every dollar of revenue. On growth, RAPID MICRO BIOSYSTEMS, INC. posted the faster year-over-year revenue change (37.3% vs 28.4%). Precipio, Inc. produced more free cash flow last quarter ($291.0K vs $-3.3M). Over the past eight quarters, RAPID MICRO BIOSYSTEMS, INC.'s revenue compounded faster (41.8% CAGR vs 40.0%).

Precipio, Inc. is a specialty diagnostic firm that develops and provides advanced oncology, genetic, and rare disease testing solutions. It primarily serves healthcare providers, clinical laboratories, and patients across the United States, with a core focus on enhancing diagnostic accuracy and improving patient health outcomes.

Rapid Micro Biosystems, Inc. develops and manufactures automated microbial detection and quality control solutions for the life sciences industry. Its core products serve biopharmaceutical manufacturers, contract development and manufacturing organizations, operating across key global markets including North America, Europe and Asia-Pacific, helping clients cut testing timelines and improve operational efficiency.

PRPO vs RPID — Head-to-Head

Bigger by revenue
RPID
RPID
1.7× larger
RPID
$11.3M
$6.8M
PRPO
Growing faster (revenue YoY)
RPID
RPID
+8.9% gap
RPID
37.3%
28.4%
PRPO
Higher net margin
PRPO
PRPO
118.5% more per $
PRPO
7.7%
-110.8%
RPID
More free cash flow
PRPO
PRPO
$3.6M more FCF
PRPO
$291.0K
$-3.3M
RPID
Faster 2-yr revenue CAGR
RPID
RPID
Annualised
RPID
41.8%
40.0%
PRPO

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PRPO
PRPO
RPID
RPID
Revenue
$6.8M
$11.3M
Net Profit
$526.0K
$-12.5M
Gross Margin
45.9%
Operating Margin
7.9%
-108.2%
Net Margin
7.7%
-110.8%
Revenue YoY
28.4%
37.3%
Net Profit YoY
244.1%
-29.3%
EPS (diluted)
$0.36
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRPO
PRPO
RPID
RPID
Q4 25
$6.8M
$11.3M
Q3 25
$6.9M
$7.8M
Q2 25
$5.6M
$7.3M
Q1 25
$4.9M
$7.2M
Q4 24
$5.3M
$8.2M
Q3 24
$5.3M
$7.6M
Q2 24
$4.5M
$6.6M
Q1 24
$3.5M
$5.6M
Net Profit
PRPO
PRPO
RPID
RPID
Q4 25
$526.0K
$-12.5M
Q3 25
$-79.0K
$-11.5M
Q2 25
$74.0K
$-11.9M
Q1 25
$-884.0K
$-11.3M
Q4 24
$-365.0K
$-9.7M
Q3 24
$-626.0K
$-11.3M
Q2 24
$-1.2M
$-12.6M
Q1 24
$-2.1M
$-13.3M
Gross Margin
PRPO
PRPO
RPID
RPID
Q4 25
45.9%
Q3 25
43.6%
Q2 25
43.2%
Q1 25
43.6%
Q4 24
49.8%
Q3 24
43.1%
Q2 24
38.1%
Q1 24
26.5%
Operating Margin
PRPO
PRPO
RPID
RPID
Q4 25
7.9%
-108.2%
Q3 25
-0.9%
-145.1%
Q2 25
-14.6%
-167.3%
Q1 25
-17.5%
-161.8%
Q4 24
-6.3%
-124.5%
Q3 24
-11.3%
-158.3%
Q2 24
-26.8%
-202.1%
Q1 24
-59.6%
-254.4%
Net Margin
PRPO
PRPO
RPID
RPID
Q4 25
7.7%
-110.8%
Q3 25
-1.1%
-146.8%
Q2 25
1.3%
-163.3%
Q1 25
-18.0%
-156.3%
Q4 24
-6.9%
-117.6%
Q3 24
-11.9%
-148.9%
Q2 24
-27.1%
-190.1%
Q1 24
-59.8%
-237.4%
EPS (diluted)
PRPO
PRPO
RPID
RPID
Q4 25
$0.36
$-0.26
Q3 25
$-0.05
$-0.26
Q2 25
$0.05
$-0.27
Q1 25
$-0.59
$-0.26
Q4 24
$-0.22
$-0.22
Q3 24
$-0.42
$-0.26
Q2 24
$-0.83
$-0.29
Q1 24
$-1.46
$-0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRPO
PRPO
RPID
RPID
Cash + ST InvestmentsLiquidity on hand
$2.7M
$20.0M
Total DebtLower is stronger
$83.0K
Stockholders' EquityBook value
$14.6M
$33.2M
Total Assets
$21.3M
$74.9M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRPO
PRPO
RPID
RPID
Q4 25
$2.7M
$20.0M
Q3 25
$2.3M
$18.9M
Q2 25
$1.1M
$18.3M
Q1 25
$1.0M
$18.9M
Q4 24
$1.4M
$16.9M
Q3 24
$1.1M
$22.0M
Q2 24
$1.3M
$37.1M
Q1 24
$776.0K
$22.4M
Total Debt
PRPO
PRPO
RPID
RPID
Q4 25
$83.0K
Q3 25
Q2 25
Q1 25
Q4 24
$383.0K
Q3 24
Q2 24
Q1 24
Stockholders' Equity
PRPO
PRPO
RPID
RPID
Q4 25
$14.6M
$33.2M
Q3 25
$13.7M
$44.3M
Q2 25
$12.3M
$54.5M
Q1 25
$11.7M
$65.5M
Q4 24
$12.1M
$75.4M
Q3 24
$11.9M
$84.4M
Q2 24
$12.1M
$94.6M
Q1 24
$12.8M
$105.9M
Total Assets
PRPO
PRPO
RPID
RPID
Q4 25
$21.3M
$74.9M
Q3 25
$21.2M
$84.4M
Q2 25
$18.8M
$75.6M
Q1 25
$17.8M
$85.4M
Q4 24
$17.0M
$98.2M
Q3 24
$17.0M
$105.8M
Q2 24
$17.3M
$117.1M
Q1 24
$16.6M
$127.7M
Debt / Equity
PRPO
PRPO
RPID
RPID
Q4 25
0.01×
Q3 25
Q2 25
Q1 25
Q4 24
0.03×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRPO
PRPO
RPID
RPID
Operating Cash FlowLast quarter
$366.0K
$-3.2M
Free Cash FlowOCF − Capex
$291.0K
$-3.3M
FCF MarginFCF / Revenue
4.3%
-29.6%
Capex IntensityCapex / Revenue
1.1%
0.8%
Cash ConversionOCF / Net Profit
0.70×
TTM Free Cash FlowTrailing 4 quarters
$359.0K
$-31.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRPO
PRPO
RPID
RPID
Q4 25
$366.0K
$-3.2M
Q3 25
$10.0K
$-9.1M
Q2 25
$353.0K
$-9.7M
Q1 25
$-44.0K
$-9.1M
Q4 24
$565.0K
$-9.9M
Q3 24
$41.0K
$-8.6M
Q2 24
$500.0K
$-10.1M
Q1 24
$-667.0K
$-15.5M
Free Cash Flow
PRPO
PRPO
RPID
RPID
Q4 25
$291.0K
$-3.3M
Q3 25
$-44.0K
$-9.1M
Q2 25
$294.0K
$-10.1M
Q1 25
$-182.0K
$-9.4M
Q4 24
$-10.0M
Q3 24
$-68.0K
$-8.8M
Q2 24
$-10.6M
Q1 24
$-16.1M
FCF Margin
PRPO
PRPO
RPID
RPID
Q4 25
4.3%
-29.6%
Q3 25
-0.6%
-116.4%
Q2 25
5.2%
-138.6%
Q1 25
-3.7%
-130.2%
Q4 24
-121.8%
Q3 24
-1.3%
-116.0%
Q2 24
-159.8%
Q1 24
-287.1%
Capex Intensity
PRPO
PRPO
RPID
RPID
Q4 25
1.1%
0.8%
Q3 25
0.8%
0.9%
Q2 25
1.0%
5.0%
Q1 25
2.8%
4.4%
Q4 24
1.2%
Q3 24
2.1%
2.9%
Q2 24
6.9%
Q1 24
10.4%
Cash Conversion
PRPO
PRPO
RPID
RPID
Q4 25
0.70×
Q3 25
Q2 25
4.77×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRPO
PRPO

Segment breakdown not available.

RPID
RPID

Products$9.3M83%
Services$2.0M17%

Related Comparisons